Navigation Links
New Federal Training Grant to Teach Doctors/Scientists Immunology
Date:8/20/2009

The Schneider Children's Hospital (SCH) campus of The Feinstein Institute for Medical Research has been awarded a prestigious $795,000 federal grant to hire and train the next generation of immunologists who will investigate diseases of the immune system to provide cutting-edge care to patients.

Manhasset, NY (Vocus) August 20, 2009 -- The Schneider Children's Hospital (SCH) campus of The Feinstein Institute for Medical Research has been awarded a prestigious $795,000 federal grant to hire and train the next generation of immunologists who will investigate diseases of the immune system to provide cutting-edge care to patients.

The new federal "T32" training grant, to be funded over the next five years by the National Institute for Allergy and Infectious Diseases, will allow Vincent Bonagura, MD, chief of pediatric immunology at SCH and a researcher at the Feinstein Institute, to train physicians to understand the basic immunobiology of the immune system and how it is involved in causing or preventing a myriad of diseases.
   
"This T32 grant, the first ever received by the North Shore-LIJ Health System, is significant because it's a national recognition of the major clinical and research expertise that Schneider Children's Hospital and the Feinstein Institute have in the area of immunology," said Arthur Klein, MD, senior vice president of children's services for the North Shore-LIJ Health System, and the executive director and chief of staff at SCH.
   
Physician/scientists selected for the new program will be able to spend time in any of the Feinstein Institute's various immunology labs. "They will have access to pediatric and adult patients who receive care for immunology-related diseases at Schneider Children's Hospital, North Shore University Hospital and LIJ Medical Center, along with patients cared for in other subspecialties that are related by the common language of immunology," said Dr. Bonagura. He added that there are an increasing number of immune-related disciplines -- including allergy, rheumatology, infectious diseases, cancers and autoimmune diseases -- that are in need of physicians and scientists trained in basic-science immunology who can expand our knowledge of the immune pathogenesis of these diseases, and provide novel and more effective therapies to treat patients.
   
"We need to train true academic doctors who will be able to advance the field," said Dr. Bonagura. The physician/scientist can also extend their training by applying for a fourth year within the Elmezzi Graduate School of Molecular Medicine (www.elmezzigraduateschool.org). The graduate school, part of the Feinstein Institute and the North Shore-LIJ Health System, trains physicians interested in becoming scientists as well. At the end of three years of training in the immunology physician/scientist program, students can earn a PhD degree in molecular medicine by completing a fourth year in the program.

Candidates for the immunology physician scientist training program will be drawn from a yearly complement of more than 110 pediatricians and internists applying for fellowship training in Allergy and Immunology Residency Training Program at Schneider Children's Hospital and LIJ Medical Center.
   
In addition to being chief of the Division of Allergy and Immunology at Schneider Children's Hospital, Dr. Bonagura is associate chair of pediatrics at SCH, and is currently a director of the American Board of Allergy and Immunology and Member of the American Board of Pediatrics. Betty Diamond, MD, director of the Feinstein's Center for Autoimmune and Musculoskeletal Diseases will be the co-director of the T32 Immunology Physician Scientist program. Dr. Diamond is an expert on rheumatic diseases, and focuses her attention on the brain problems associated with lupus.
   
The federal training grant fits with the mission of the Feinstein to discover and understand the causes and underlying mechanisms of human diseases, and to rapidly translate this information into diagnostic and therapeutic solutions for patients. Dr. Bonagura's lab focuses on human host defense mechanisms made against human papillomaviruses.

Contact
Jamie Talan
Science writer-in-residence
516-562-1232 (w) or 631-682-8781 (c)

###

Read the full story at http://www.prweb.com/releases/Feinstein_Institute/Allergy_Immunology/prweb2772464.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MDMA Names New Director of Federal Affairs
2. Federal research plan to determine nanotech risks fails to deliver
3. Federal Employee Program Maintains Low Health Premiums In 2008
4. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
5. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
6. ACM Helps Medicaid Programs Comply With Federal Deficit Reduction Act Mandates
7. Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid
8. HIV/AIDS Cases Among State and Federal Prison Inmates Fell for the Sixth Straight Year During 2005
9. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
10. Federal Trade Commission Attempts To Suppress Best-Selling Authors First Amendment Rights
11. CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Federal Training Grant to Teach Doctors/Scientists Immunology
(Date:2/10/2016)... ... ... LaserShip, a regional parcel carrier that services the eastern U.S., donated and delivered ... order to aid in the Flint water crisis. In 2014, LaserShip acquired Prestige Delivery ... only 15 miles away from Flint. , “We have deep roots in the local ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... As part ... two webinars in February 2016. Each webinar features a dynamic expert and thoughtful ... benefit their athletes, patients and facilities. Both events are free to attend, but ...
(Date:2/10/2016)... ... February 10, 2016 , ... The Wickman ... created to assist the local community. Pledging to select a new beneficiary every ... in the area. Their goal is to bring community awareness to important local ...
(Date:2/10/2016)... Thornton, CO (PRWEB) , ... February 10, 2016 , ... ... to announce the practice is now accepting new dental patients and families in the ... expect exceptional dental care services from cleanings to cosmetic dentistry, and all in the ...
(Date:2/10/2016)... ... ... Gout is like no other joint pain. It strikes suddenly, like flicking on ... redness. It is triggered by the crystallization of uric acid within the joints. It ... to the February 2016 issue of Harvard Men's Health Watch. , The large joint ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 Mylan N.V. (NASDAQ, TASE: MYL) today ... ended December 31, 2015. --> ... total revenues of $9.45 billion, up 28% on a ... revenues of $9.43 billion. Excluding the impact of the ... branded generics business (the "EPD Business"), full year adjusted ...
(Date:2/10/2016)... 10, 2016 CSI Specialty Group (CSI) expanded ... of the Specialty Pharmacy Podcast. A free, weekly show, ... providing real-world education, discussion and context amongst specialty pharmacy ... --> The Specialty Pharmacy Podcast, hosted ... Specialty Group Suzette DiMascio, CHE, CMCE, CPC, is available ...
(Date:2/10/2016)... , Feb. 10, 2016 Urologix, the ... the treatment of Benign Prostatic Hyperplasia (BPH), announces new ... Ash Keswani , a medical device industry veteran of ... the Limited Liability Company.  Plymouth, ... service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, will ...
Breaking Medicine Technology: